COVID-19 preclinical drug discovery and development

In winter 2021, the Academy is calling for new project submissions to our COVID-19 preclinical drug development database. We are mapping ongoing and emerging COVID-19 preclinical drug development research to help researchers and funders identify opportunities for collaboration, avoid duplication of effort and prioritise the most promising research.